4.5 Article

Genome-Wide Association Study of Intelligence: Additive Effects of Novel Brain Expressed Genes

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jaac.2012.01.006

Keywords

cognitive ability; genetics; SNPs; ADHD; haplotype

Funding

  1. National Institute of Health [MH059126, MH085518, MH01966, MH071852, MH058277, NS54124]
  2. UCLA Informatics Center for Neurogenetics and Neurogenomics
  3. [NS062691]

Ask authors/readers for more resources

Objective: The purpose of the present study was to identify common genetic variants that are associated with human intelligence or general cognitive ability. Method: We performed a genome-wide association analysis with a dense set of 1 million single-nucleotide polymorphisms (SNPs) and quantitative intelligence scores within an ancestrally homogeneous family sample of 656 individuals with at least one child affected by attention-deficit/hyperactivity disorder (ADHD). Results: Haplotype trend regression analysis with sliding four-SNP windows identified haplotypes of genome-wide significance in genes involved in synaptic signaling (KIF16B; p = 1.27E-08) and neurodevelopment (PAX5; p = 3.58E-08), and highlight findings from a recent genetic study of cognitive ability (RXRA; p = 7.7E-08; GYPC; p = 2.5E-07). Further interrogation of SNPs within top haplotypes reveals that the minor alleles are associated with higher intelligence, whereas others are associated with relatively lower (but still average range) intelligence. Effects of the eight genes are additive, as a greater number of the associated genotypes in a given individual predict higher intelligence (p = 5.36E-08) and account for 8% of variance in intelligence. Conclusions: Analyses that examine additive genetic effects may be useful in identifying regions where the additive effects of SNPs have a significant effect on phenotype. These results describe novel variants and additive effects of genes involved in brain development on variability in intelligence within an ADHD sample. The precise mechanisms of these loci in relation to determining individual differences in general cognitive ability require further investigation. J. Am. Acad. Child Adolesc. Psychiatry, 2012;51(4):432-440.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Developmental

Physical Health, Media Use, and Mental Health in Children and Adolescents With ADHD During the COVID-19 Pandemic in Australia

Emma Sciberras, Pooja Patel, Mark A. Stokes, David Coghill, Christel M. Middeldorp, Mark A. Bellgrove, Stephen P. Becker, Daryl Efron, Argyris Stringaris, Stephen V. Faraone, Susannah T. Bellows, Jon Quach, Tobias Banaschewski, Jane McGillivray, Delyse Hutchinson, Tim J. Silk, Glenn Melvin, Amanda G. Wood, Anna Jackson, George Loram, Lidia Engel, Alicia Montgomery, Elizabeth Westrupp

Summary: The study found that COVID-19 restrictions had negative impacts on children with ADHD, leading to reduced physical activity and outdoor time, decreased enjoyment in activities, and increased screen time and negative emotions. However, some parents reported positive changes in their children, such as increased family time during this period.

JOURNAL OF ATTENTION DISORDERS (2022)

Article Psychology, Developmental

Long-Term Treatment With Extended-Release Methylphenidate Treatment in Children Aged 4 to <6 Years

Ann C. Childress, Henry C. Foehl, Jeffrey H. Newcorn, Stephen Faraone, Benjamin Levinson, Akwete L. Adjei

Summary: The study on the long-term safety and symptom control of extended-release methylphenidate in children aged 4 to <6 years showed that most treatment-emergent adverse events were of mild or moderate severity, weight and height z scores as well as obesity rates decreased significantly, with insomnia reported in 9% and hypertension in 6.7%, while ADHD symptom control was maintained.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2022)

Article Psychology, Developmental

Association of Parent-Rated Sleep Disturbances With Attention-Deficit/Hyperactivity Disorder Symptoms: 9-Year Follow-up of a Population-Based Cohort Study

Corentin J. Gosling, Samuele Cortese, Eric Konofal, Michel Lecendreux, Stephen V. Faraone

Summary: This study examined the association between sleep disturbances and ADHD symptoms over a 9-year period, finding that sleep disturbances at age 13 predicted increased ADHD symptoms at age 18, while ADHD symptoms at age 9 predicted increased sleep disturbances at age 13. The findings highlight the importance of identifying these issues for preventive interventions.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2023)

Review Biochemistry & Molecular Biology

Association between ADHD and vision problems. A systematic review and meta-analysis

Alessio Bellato, John Perna, Preethi S. Ganapathy, Marco Solmi, Andrea Zampieri, Samuele Cortese, Stephen Faraone

Summary: This study conducted a systematic review and meta-analysis to investigate the association between attention-deficit/hyperactivity disorder (ADHD) and eye disorders as well as altered visual function. The findings suggest that ADHD is associated with an increased risk of certain vision problems and visual function impairments, but not with structural changes in the eye.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior

Renee Kleine Deters, I. Hyun Ruisch, Stephen Faraone, Catharina A. Hartman, Marjolein Luman, Barbara Franke, Jaap Oosterlaan, Jan K. Buitelaar, Jilly Naaijen, Andrea Dietrich, Pieter J. Hoekstra

Summary: Genetic risk for antisocial and aggressive behaviors is related to amygdala shape alterations, indicating genetic sharing across different DBD and ASB and aggression-related phenotypes. Additionally, vertex-based shape analysis is useful in genetic studies of ASB, aggression, and DBDs.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Predicting efficacy of viloxazine extended-release treatment in adults with ADHD using an early change in ADHD symptoms: Machine learning Post Hoc analysis of a phase 3 clinical trial

Stephen V. Faraone, Roberto Gomeni, Joseph T. Hull, Soumya A. Chaturvedi, Gregory D. Busse, Zare Melyan, Welton O'Neal, Jonathan Rubin, Azmi Nasser

Summary: Early response to viloxazine ER treatment predicts efficacy outcome in ADHD patients, and the predictive model is consistent across different age groups.

PSYCHIATRY RESEARCH (2022)

Article Psychology, Developmental

Machine Learning and MRI-based Diagnostic Models for ADHD: Are We There Yet?

Yanli Zhang-James, Ali Shervin Razavi, Martine Hoogman, Barbara Franke, Stephen V. Faraone

Summary: This systematic review examines the literature on the development of magnetic resonance imaging (MRI)-based diagnostic classifiers for attention-deficit/hyperactivity disorder (ADHD) using machine learning (ML). It found variations in MRI modalities, ML models, cross-validation and testing methods, and sample sizes among the studies. The review also highlights the importance of large multi-modal imaging datasets and the potential combination with other types of data to develop clinically useful imaging classification tools for ADHD in the future.

JOURNAL OF ATTENTION DISORDERS (2023)

Article Psychiatry

Can machine learning identify childhood characteristics that predict future development of bipolar disorder a decade later?

Mai Uchida, Qasim Bukhari, Maura DiSalvo, Allison Green, Giulia Serra, Chloe Hutt Vater, Satrajit S. Ghosh, Stephen V. Faraone, John D. E. Gabrieli, Joseph Biederman

Summary: This study developed a quantitative predictive model for bipolar disorder using machine learning algorithms and clinical data. The predictors included behavioral problems, school functioning, and anxiety/depression and aggression scales. The results have important clinical and scientific implications for assessing the risk of bipolar disorder in children.

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

Biographical-Item Neurosciences

In Memoriam: Joseph Biederman

Stephen V. Faraone

BIOLOGICAL PSYCHIATRY (2023)

Review Clinical Neurology

Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis

Nevena V. Radonjic, Alessio Bellato, Nayla M. Khoury, Samuele Cortese, Stephen V. Faraone

Summary: This study conducted a systematic review and meta-analysis to assess the efficacy, acceptability, and tolerability of nonstimulants in adults with ADHD. The results showed that atomoxetine, guanfacine, and viloxazine ER were significantly more effective than placebo in treating ADHD. However, atomoxetine had poorer tolerability compared to placebo.

CNS DRUGS (2023)

Article Psychology, Developmental

Progress and Pitfalls in the Provision of Quality Care for Adults With Attention Deficit Hyperactivity Disorder in Primary Care

Elisabeth F. Callen, Tarin L. Clay, Jillian Alai, David W. Goodman, Lenard A. Adler, Joel Shields, Stephen V. Faraone

Summary: This study aimed to assess the changes in quality care for adults with ADHD from 2010 to 2020. The results showed an increase in the achievement of quality measures over time, but none of the patients achieved more than six out of ten measures in any year. Small but significant effects were observed for sex, race, ethnicity, practice ownership, practice type, and age.

JOURNAL OF ATTENTION DISORDERS (2023)

Article Endocrinology & Metabolism

Association of ADHD symptoms with type 2 diabetes and cardiovascular comorbidities in adults receiving outpatient diabetes care

Ali Zare Dehnavi, Yanli Zhang-James, Dan Draytsel, Ben Carguello, Stephen V. Faraone, Ruth S. Weinstock

Summary: This study found that approximately 49.2% of adults with type 2 diabetes (T2D) met the diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD). However, there was no direct association between these symptoms and cardiovascular diseases or diabetic control. Further research is needed to clarify the relationship between ADHD symptoms, diabetic control, and comorbidities.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2023)

Review Biochemistry & Molecular Biology

Association between Autism Spectrum Disorder (ASD) and vision problems. A systematic review and meta-analysis

John Perna, Alessio Bellato, Preethi S. Ganapathy, Marco Solmi, Andrea Zampieri, Stephen V. Faraone, Samuele Cortese

Summary: This study conducted a systematic review and meta-analysis to investigate the association between vision and/or eye disorders and Autism Spectrum Disorder (ASD). The findings suggest that ASD is associated with functional vision problems and structural alterations of the eye. However, further research is needed to clarify the causal relationship between ASD and vision problems.

MOLECULAR PSYCHIATRY (2023)

Correction Biochemistry & Molecular Biology

Association between autism spectrum disorder (ASD) and vision problems. A systematic review and meta-analysis (Jul, 10.1038/s41380-023-02143-7, 2023)

John Perna, Alessio Bellato, Preethi S. Ganapathy, Marco Solmi, Andrea Zampieri, Stephen V. Faraone, Samuele Cortese

MOLECULAR PSYCHIATRY (2023)

Review Pharmacology & Pharmacy

Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management

Lisa O'Connor, Stephanie Carbone, Anthony Gobbo, Hilary Gamble, Stephen Faraone

Summary: This article provides an overview of pharmacological treatment options for pediatric attention-deficit disorder (ADHD), including stimulant and non-stimulant medications. It offers detailed information on new medication options, such as anesthetic agents, extended-release forms, and novel adjunctive medications. These additions are beneficial for clinicians in their treatment toolbox.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)

No Data Available